Open AccessSystematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
Author(s) -
Yaoyao Zhou,
GuiQi Zhu,
Yue Wang,
Ji-Na Zheng,
Lu-Yi Ruan,
Cheng Zhang,
Bin Hu,
Shihua Fu,
MingHua Zheng
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.7832
Subject(s) - medicine , rosuvastatin , hepatocellular carcinoma , cochrane library , meta analysis , incidence (geometry) , oncology , atorvastatin , observational study , family medicine , traditional medicine , physics , optics
Usage of statins is suggested to decrease the incidence of HCC. When it comes to different statin subtypes, the chemopreventive action remains controversial. We aim to compare the usage of different statins and reduction of HCC risk.